Production (Stage)
ProMIS Neurosciences, Inc.
PMN
$0.4808
-$0.023-4.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 37.70K | 4.32M | 2.56M | 1.63M | 3.80K |
| Gross Profit | -37.70K | -4.32M | -2.56M | -1.63M | -3.80K |
| SG&A Expenses | 2.00M | -1.82M | 1.87M | 1.09M | 1.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.46M | 2.50M | 4.43M | 2.71M | 3.68M |
| Operating Income | -7.46M | -2.50M | -4.43M | -2.71M | -3.68M |
| Income Before Tax | -7.35M | -238.20K | 9.28M | -2.62M | -3.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.35M | -238.20K | 9.28M | -2.62M | -3.64M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.35M | -238.20K | 9.28M | -2.62M | -3.64M |
| EBIT | -7.46M | -2.50M | -4.43M | -2.71M | -3.68M |
| EBITDA | -- | -2.50M | -4.43M | -2.71M | -3.67M |
| EPS Basic | -0.21 | -0.01 | 0.31 | -0.13 | -0.19 |
| Normalized Basic EPS | -0.13 | 0.06 | 0.19 | -0.08 | -0.12 |
| EPS Diluted | -0.21 | -0.01 | 0.31 | -0.13 | -0.19 |
| Normalized Diluted EPS | -0.13 | 0.06 | 0.19 | -0.08 | -0.12 |
| Average Basic Shares Outstanding | 34.85M | 34.82M | 30.02M | 19.77M | 19.53M |
| Average Diluted Shares Outstanding | 34.85M | 34.82M | 30.07M | 19.77M | 19.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |